PENILE SQUAMOUS CELL CARCINOMA
Clinical trials for PENILE SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PENILE SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PENILE SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail aims to shrink penile cancer before surgery
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy that attacks cancer cells with a specific protein) and Pucotenlimab (an immunotherapy that boosts the immune system)—in men with advanced penile cancer that is hard to treat with surgery al…
Matched conditions: PENILE SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New hope for advanced penile cancer: drug combo targets tough cases
Disease control Not yet recruitingThis study tests a new combination of two drugs (becotatug vedotin and pucotenlimab) in 20 adults with advanced penile cancer that has spread and is EGFR-positive. Participants must have failed or be unable to tolerate chemotherapy. The goal is to see if the treatment can shrink …
Matched conditions: PENILE SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC